The Liver Week 2020 Virtual

The Liver Week 2020 Virtual Conference [DAY 2: Friday, August 14, 2020]

08:30-10:50: Real Time Discussion
Policy Symposium. Nationwide Policies to Eliminate Hepatitis C; Dong Jin Suh (Korean Liver Foundation), W. Ray Kim (Stanford Univ., USA), Han Chu Lee (Univ. of Ulsan)

08:30-09:00: Hepatitis C Elimination Program in Taiwan: “The Taiwan Hepatitis C Policy Guideline 2018 - 2025”Chien-Jen Chen (Former Vice President of Taiwan, Academia Sinica, Taiwan)
09:00-09:20: HCV Elimination in Taiwan: What and How We Have Achieved from the Beginning till TodayJia-Horng Kao (National Taiwan Univ., Taiwan)
09:20-09:40: HCV Elimination in Japan: The Japanese Policy and OutcomeTatsuya Kanto (National Center for Global Health and Medicine, Japan)
09:40-10:00: National Policies on Hepatitis C in KoreaHyung-Min Lee (Korea Centers for Disease Control & Prevention)
10:00-10:20: Current Status and Suggestions for Hepatitis C Control in KoreaDo Young Kim (Yonsei Univ.)
10:20-10:50: Panel Discussion

08:30-10:20: Real Time Discussion
ISALPDC 3. Alcohol Promotion of Cancer; Wen Xing Ding (Univ. of Kensas, USA), Yingzi Yang (Harvard Univ., USA)

08:30-08:50: Hippo Pathway Regulation of Liver Inflammation and CancerYingzi Yang (Harvard Univ., USA)
08:50-09:10: Complement C3, tRNA-derived Fragments Gly-tRFs, and Alcoholic Liver DiseaseSongqing He (Guangxi Medical Univ., China)
09:10-09:30: Autophagy and CancerWen-Xing Ding (Univ. of Kensas, USA)
09:30-09:50: Risk Factors for Alcohol-Related Hepatocellular CarcinomaMakiko Taniai (Tokyo Women’s Medical Univ., Japan)
09:50-10:00: Catecholamine Signaling Pathway Protects Alcoholic Fatty Liver by Inducing Growth Differentiation Factor 15Hee-Hoon Kim (KAIST)
10:00-10:20: Round Table Discussions

08:30-08:50: Transcriptomic Signature of Nonalcoholic Fatty Liver DiseaseMurim Choi (Seoul National Univ.)
08:50-09:10: Immunologic Circuits of Hepatocellular CarcinomaSu Jong Yu (Seoul National Univ.)
09:10-09:30: Interactive Interface between Gut Microbiome and Immunome in Alcohol-Related Liver DiseaseBernd Schnabl (Univ. of California San Diego, USA)
09:30-09:50: Novel Immunomodulating Pharmabiotics for Hepatocellular CarcinomaHan Soo Park (GIST)

09:50-10:50: Special Interest Group Forum. Clinical Issues in Autoimmune Liver Disease

09:50-10:10: Pathology of Autoimmune Hepatitis, Primary Biliary Cholangitis, and Overlap SyndromeMasayoshi Kage (Kurume Univ., Japan)
10:10-10:30: Autoimmune Hepatitis: From Bench to ClinicXiong Ma (Shanghai Jiao Tong Univ., China)
10:30-10:50: Primary Biliary Cholangitis: Unsolved Issues and New TreatmentGideon M. Hirschfield (Univ. of Birmingham, UK)

10:30-12:45: Real Time Discussion
ISALPDC 4. Translational Studies and Public Health on Alcoholic Liver Disease; Shiv Kumar Sarin (Institute of Liver and Biliary Science, India), Suthat Liangpunsakul (Indiana Univ., USA)

10:30-10:50: Prognostic Potential of LncRNAs for Alcoholic Liver Disease PatientsSuthat Liangpunsakul (Indiana Univ., USA)
10:50-11:10: Predictors of Steroid Non-Response and New Approaches in Severe Alcoholic HepatitisShiv Kumar Sarin (Institute of Liver and Biliary Science, India)
11:10-11:30: Global and Regional Impacts of Alcohol Use on Public HealthDong Joon Kim (Hallym Univ.)
11:30-11:50: Impact of Genetic Traits and Drinking Mode on Alcoholic Liver Disease in ChinaJia Xiao (Fujian Normal Univ., China)
11:50-12:10: TAPPY: Multi-Professional Care of Alcoholic PatientsMasahiro Kikuchi (Tokyo Medical Center, Japan)
12:10-12:20: The Evolution of Liver Donor Liver Transplantation for Alcoholic Liver Cirrhosis in a High-Volume Center: The Eastern Perspective Jeffrey Samuel Co (Kaohsiung Chang Memorial Hospital, Taiwan)
12:20-12:40: Round Table Discussions
12:40-12:45: Closing Remarks

11:00-12:00: Real Time Discussion
Plenary Presentation 2; Jin Mo Yang (The Catholic Univ. of Korea), Chul Ju Han (Korea Cancer Center Hospital), Yang Won Nah (Univ. of Ulsan)

13:00-14:10: Real Time Discussion
KLTS-KAHBPS-KLCA Joint Symposium. Treatment Options for HCC beyond the Milan Criteria in Patients with Marginal Liver Function; Jong Young Choi (The Catholic Univ. of Korea), Shin Hwang (Univ. of Ulsan)

13:00-13:20: Locoregional TherapyYoon Jun Kim (Seoul National Univ.)
13:20-13:40: Down-Staging Living Donor Liver TransplantationJae Geun Lee (Yonsei Univ.)
13:40-14:00: Is There a Role for TKIs and Immune Checkpoint Inhibitors?Thomas Yau (Univ. of Hong Kong, China)
14:00-14:10: Discussion

13:00-14:00: KLCA Symposium 2. Updates in Diagnosis and Biomarkers of Hepatocellular Carcinoma

13:00-13:20: Established and Potential Biomarkers of Hepatocellular Carcinoma with Focus on Recent Clinical TrialsJoong-Won Park (National Cancer Center Korea)
13:20-13:40: Imaging Biomarkers in the Era of Precision MedicineSun Young Lee (Yonsei Univ.)
13:40-14:00: Pathologic Biomarkers that Indicate the Aggressiveness and Prognosis of Hepatocellular CarcinomaYoung Nyun Park (Yonsei Univ.)

13:30-14:40: Real Time Discussion
General Oral Presentation 2; Young Oh Kweon (Kyungpook National Univ.), Sang-Jae Park (National Cancer Center Korea )

14:10-15:10: KAHBPS-KLTS Joint Symposium. Optimal Use of ICG Fluorescence Technology in Daily Practice

14:10-14:30: Tumor Localization in Oncologic Surgery Masaki Ueno (Wakayama Medical Univ., Japan)
14:30-14:50: Anatomical Liver ResectionDai Hoon Han (Yonsei Univ.)
14:50-15:10: Donor HepatectomyYoung Rock Choi (Seoul National Univ.)

14:20-15:20: Real Time Discussion
KASL Plenary Presentation; Seong Gyu Hwang (CHA Univ.), Kwon Yoo (Ewha Womans Univ.)

15:20-15:40: New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B InfectionIl Han Song (Dankook Univ.)
15:40-16:00: Non-Invasive Diagnosis and Biomarkers in Alcohol-Related Liver DiseaseSuthat Liangpunsakul (Indiana Univ., USA)
16:00-16:20: Quantitative Imaging Biomarker in the Assessment of Hepatic Fibrosis and SteatosisWoo Kyoung Jeong (Sungkyunkwan Univ.)
16:20-16:40: Clinical Application of Liquid Biopsy as a Prognostic Biomarker in Hepatocellular CarcinomaSoo Young Park (Kyungpook National Univ.)

15:30-17:00: Real Time Discussion
KASL-KAHBPS-KLTS Joint Symposium. How to Improve Outcome in Critically Ill Patients Awaiting Liver Transplantation; Soon Ho Um (Korea Univ.), Hee Chul Yu (Chonbuk National Univ.)

15:30-15:50: Liver Transplantation for Patients with Severe Alcoholic Hepatitis: Inside Stories of Patient Selection and Pretransplant ManagementPhilippe Mathurin (Chu De Lille, France)
15:50-16:10: Risk Stratification and Optimal Management for Liver Transplantation in Acute-on-Chronic Liver FailureDong Hyun Sinn (Sungkyunkwan Univ.)
16:10-16:30: Risk Stratification and Optimal Management for Liver Transplantation in Acute Liver Failure Young-dong Yu (Korea Univ.)
16:30-16:50: How to Improve Post-Transplant Outcomes in Patients with High MELD Scores Dong-Hwan Jung (Univ. of Ulsan)
16:50-17:00: Discussion